Compare IMNN & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNN | VS |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.6M |
| IPO Year | 2000 | 2017 |
| Metric | IMNN | VS |
|---|---|---|
| Price | $0.54 | $0.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.20 | N/A |
| AVG Volume (30 Days) | ★ 133.1K | 12.2K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.97 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,183,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3711.30 |
| 52 Week Low | $0.50 | $0.69 |
| 52 Week High | $4.35 | $1.86 |
| Indicator | IMNN | VS |
|---|---|---|
| Relative Strength Index (RSI) | 23.75 | 30.10 |
| Support Level | $0.50 | N/A |
| Resistance Level | $1.28 | $1.18 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.96 | 6.00 |
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.